The genetics of major depression.
- Authors
- Flint, Jonathan; Kendler, Kenneth S
- Year
- 2014
- Journal
- Neuron
- PMID
- 24507187
- DOI
- 10.1016/j.neuron.2014.01.027
- PMCID
- PMC3919201
Major depression is the commonest psychiatric disorder and in the U.S. has the greatest impact of all biomedical diseases on disability. Here we review evidence of the genetic contribution to disease susceptibility and the current state of molecular approaches. Genome-wide association and linkage results provide constraints on the allele frequencies and effect sizes of susceptibility loci, which we use to interpret the voluminous candidate gene literature. We consider evidence for the genetic heterogeneity of the disorder and the likelihood that subtypes exist that represent more genetically homogenous conditions than have hitherto been analyzed.
Power to Detect a Locus using GWASSimulated data are plotted to assess power under two different sets of conditions: varying the size of the locus effect (expressed as an odds ratio [OR]) and varying the number of loci used in the GWASs. Results are shown for an Affymetrix 500K array (which yields approximately 400,000 useful genotypes per individual) and simulations using all variants in HapMap (release 2). The simulations are taken from Spencer et al. (2009). The significance level was set at 5 Γ 10β8. Sample size is shown for the number of cases required; the simulations assume an equal number of controls.
GWAS Sample SizeSample sizes (horizontal axis) required for a GWAS to have 80% probability of detecting the number of loci shown on the vertical axis, at a significance level of 5 Γ 10β8. Results are shown for four complex traits: two disease and two quantitative phenotypes. The graph assumes that the number of loci detected increases linearly with increasing sample size (data are from Frayling et al., 2007, Lango Allen et al., 2010, Loos et al., 2008, Park et al., 2010, Scuteri et al., 2007, Speliotes et al., 2010, Thorleifsson et al., 2009, Wen et al., 2012, Willer et al., 2009).
The Effect of Disease Prevalence on Sample Size to Detect at Least One Locus for Major DepressionSample sizes (horizontal axis) required for a GWAS to have 80% probability of detecting at least one locus contributing to the risk of major depression, plotted against disease prevalence (vertical axis). In most surveys, major depression has a prevalence of about 10%. The genetic architecture of major depression is assumed to be either similar to height (black continuous line) or weight (red dotted line).
No entities extracted from this document yet.
No uploaded files.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Are polygenic scores for psychiatric and substance use outcomes "ready" for clinical application? Current state and next steps. | Dick DM et al. | β | 2026 | β |
| Biologically Annotated Heterogeneity of Depression Through Neuroimaging Normative Modeling. | Li J et al. | β | 2026 | β |
| Deep Phenotyping at Scale: Study Protocol for the Korean Mood Disorder Genetic Study-Depression (KOMOGEN-D). | Min S et al. | β | 2026 | β |
| Impact of a personalized antidepressant prescription using genetics, socio-demographic and clinical data in major depressive disorder patients: A clinical study. | Saudreau B et al. | β | 2026 | β |
| Neuroimaging Insights Into the Neurophysiological Subtypes of Major Depressive Disorder. | Sun X et al. | β | 2026 | β |
| The genetic architecture of reproductive subtypes of depression in females. | Crestol A et al. | β | 2026 | β |
| The predicament of heritable confounders. | Cai N et al. | β | 2026 | β |
| Acupoint massage: a comprehensive descriptive review of its forms, applications, and underlying mechanisms. | Yao C et al. | β | 2025 | β |
| Are conventional antidepressants enough? The gut microbiome and nanocarrier-based delivery systems as future prospects for depression treatment. | Gastaldo-JordΓ‘n I et al. | β | 2025 | β |
| Brain connectivity and transcriptomic similarity inform abnormal morphometric similarity patterns in first-episode, treatment-naΓ―ve major depressive disorder. | Xue K et al. | β | 2025 | β |
| Brain microstate features of patients with depression: A transcranial magnetic stimulation and electroencephalographic (TMS-EEG) study. | Zhang J et al. | β | 2025 | β |
| Distinct prefrontal cortex alterations in confirmed and suspected depression individuals with different perceived stress during an emotional autobiographical memory task: One fNIRS investigation. | Zhang Y et al. | β | 2025 | β |
| DNA methylation studies in mouse models of depression: a systematic review. | Billah MM et al. | β | 2025 | β |
| Dynamic Brain Network Biomarkers for Depression Prediction: A Multi-Cohort Analysis of Global Neuroimaging Databases. | Peng Y et al. | β | 2025 | β |
| G9a an Epigenetic Therapeutic Strategy for Neurodegenerative Conditions: From Target Discovery to Clinical Trials. | Bellver-Sanchis A et al. | β | 2025 | β |
| Genomic risk prediction for depression in a large prospective study of older adults of European descent. | Yu C et al. | β | 2025 | β |
| Global burden of depression and anxiety disorders in older adults, 1990-2019: An analysis of age-period-cohort and temporal-spatial patterns. | Li R et al. | β | 2025 | β |
| <i>miRNAs</i> in Major Depression: Possible Association of <i>miR-17</i> and <i>miR-92</i> with Childhood Traumas. | Mert A et al. | β | 2025 | β |
| Lost in translation: toward clinically effective translational research. | Tan VTY et al. | β | 2025 | β |
| <i>Guanxi</i> beliefs, self-efficacy beliefs, and depressive symptoms-Analysis of the effects of Chinese-style special relationships. | Li G et al. | β | 2025 | β |
| Parental migration patterns and children depression in China's ethnic minority rural areas: A latent profile analysis. | Chen Y et al. | β | 2025 | β |
| POLYCYSTIC OVARY SYNDROME: ORIGINS AND IMPLICATIONS: Genetics of polycystic ovary syndrome (PCOS). | Louwers YV et al. | β | 2025 | β |
| Polygene by environment interactions predicting depressive outcomes. | Grillo AR | β | 2025 | β |
| Polygenic risk for depression and resting-state functional connectivity of subgenual anterior cingulate cortex in young adults. | Chen Y et al. | β | 2025 | β |
| Review: Child Psychiatry in the Era of Genomics: The Promise of Translational Genetics Research for the Clinic. | Fitzpatrick SE et al. | β | 2025 | β |
| The Association of Mitochondrial tRNA<sup>Cys</sup> G5783A Mutation with Major Depressive Disorder in Two Han Chinese Families. | Jing P et al. | β | 2025 | β |
| The biological relationship among depression, vitamins B<sub>9</sub>, B<sub>12</sub>, and D, and genetic variants: a systematic review. | Soriano-Gonzalez R et al. | β | 2025 | β |
| Transcriptomic decoding of brain function and cerebral blood flow impairments in first-episode drug-naive patients with major depressive disorder. | Tu M et al. | β | 2025 | β |
| Traumatic life events as predictors for depression in middle-aged men and women: A Finnish twin study. | Piirtola M et al. | β | 2025 | β |
| Unraveling Hierarchical Brain Dysfunction in Major Depressive Disorder: A Multimodal Imaging and Transcriptomic Approach. | Xiayan C et al. | β | 2025 | β |
| Unraveling the Shared Genetic Architecture and Polygenic Overlap Between Loneliness, Major Depressive Disorder, and Sleep-Related Traits. | Rehman Z et al. | β | 2025 | β |
| Abnormal neural sensitivity to rewards as a candidate process of high depression risk in the <i>FMR</i>1 premutation: A pilot study. | Harold R et al. | β | 2024 | β |
| Acupressure for depression: A systematic review and meta-analysis. | Li J et al. | β | 2024 | β |
| A genetic risk score to predict treatment nonresponse in psychotic depression. | Ter Hark SE et al. | β | 2024 | β |
| Alcohol milestones and internalizing, externalizing, and executive function: longitudinal and polygenic score associations. | Paul SE et al. | β | 2024 | β |
| Altered intersubject functional variability of brain white-matter in major depressive disorder and its association with gene expression profiles. | Gai Q et al. | β | 2024 | β |
| An association study of m6A methylation with major depressive disorder. | Li Y et al. | β | 2024 | β |
| Animal and plant protein intake association with mental health, tryptophan metabolites pathways, and gut microbiota in healthy women: a cross-sectional study. | Soveid N et al. | β | 2024 | β |
| An overview of major depression disorder: The endocannabinoid system as a potential target for therapy. | ZarazΓΊa-GuzmΓ‘n S et al. | β | 2024 | β |
| Associations of adolescent substance use and depressive symptoms with adult major depressive disorder in the United States: NSDUH 2016-2019. | Xu C et al. | β | 2024 | β |
| Biomarker-Guided Tailored Therapy in Major Depression. | Perna G et al. | β | 2024 | β |
| Common and distinct neural correlates of emotional processing in individuals at familial risk for major depressive disorder and bipolar disorder: A comparative meta-analysis. | Qin K et al. | β | 2024 | β |
| Depression and health literacy among adolescents and adults in Germany: findings from two representative samples. | KΓΆnig L et al. | β | 2024 | β |
| Developing a translational research framework for MDD: combining biomolecular mechanisms with a spiraling risk factor model. | van Baalen M et al. | β | 2024 | β |
| Differential etiologic associations of heroin use and prescription opioid misuse with psychopathology. | Dash GF et al. | β | 2024 | β |
| Edge-centric connectome-genetic markers of bridging factor to comorbidity between depression and anxiety. | Chen Z et al. | β | 2024 | β |
| Elucidating genetic and molecular basis of altered higher-order brain structure-function coupling in major depressive disorder. | Long H et al. | β | 2024 | β |
| Exploring intra-diagnosis heterogeneity and inter-diagnosis commonality in genetic architectures of bipolar disorders: association of polygenic risks of major psychiatric illnesses and lifetime phenotype dimensions. | Baek JH et al. | β | 2024 | β |
| Exploring the potential of drug repurposing for treating depression. | Verma C et al. | β | 2024 | β |
| Familial coaggregation and shared genetic influence between major depressive disorder and gynecological diseases. | Chen CY et al. | β | 2024 | β |
| Fish consumption and depression in Korean population: The Korea National Health and Nutrition Examination Survey, 2013-2021. | Kim E et al. | β | 2024 | β |
| Genetic polymorphism involved in major depressive disorder: a systemic review and meta-analysis. | Suktas A et al. | β | 2024 | β |
| Genomics Research of Lifetime Depression in the Netherlands: The BIObanks Netherlands Internet Collaboration (BIONIC) Project. | Huider F et al. | β | 2024 | β |
| Health-Related Behaviors and Risk of Common Age-Related Brain Diseases Across Severities of Genetic Risk. | Marini S et al. | β | 2024 | β |
| Hemochromatosis neural archetype reveals iron disruption in motor circuits. | Loughnan R et al. | β | 2024 | β |
| Identification of novel endoplasmic reticulum-related genes and their association with immune cell infiltration in major depressive disorder. | Chang L et al. | β | 2024 | β |
| Identifying two distinct neuroanatomical subtypes of first-episode depression using heterogeneity through discriminative analysis. | Chen Y et al. | β | 2024 | β |
| Impact of air pollution exposure on the severity of major depressive disorder: Results from the DeprAir study. | Borroni E et al. | β | 2024 | β |
| Influence of BDNF Val66Met genetic polymorphism in Major Depressive Disorder and Body Mass Index: Evidence from a meta-analysis of 6481 individuals. | PΓ©rez-GutiΓ©rrez AM et al. | β | 2024 | β |
| Investigating the genetic relationship of intracranial and subcortical brain volumes with depression and other psychiatric disorders. | GarcΓa-MarΓn LM et al. | β | 2024 | β |
| Leveraging DNA methylation to predict treatment response in major depressive disorder: A critical review. | Dahrendorff J et al. | β | 2024 | β |
| Microglial circ-UBE2K exacerbates depression by regulating parental gene UBE2K via targeting HNRNPU. | Cai Y et al. | β | 2024 | β |
| Mood and microbes: a comprehensive review of intestinal microbiota's impact on depression. | Luqman A et al. | β | 2024 | β |
| Multimodal integration of neuroimaging and genetic data for the diagnosis of mood disorders based on computer vision models. | Lee S et al. | β | 2024 | β |
| Neuroimaging and epigenetic analysis reveal novel epigenetic loci in major depressive disorder. | Yang HH et al. | β | 2024 | β |
| Physical and mental health in adolescence: novel insights from a transdiagnostic examination of FitBit data in the ABCD study. | Damme KSF et al. | β | 2024 | β |
| Polygenic risk for depression and anterior and posterior hippocampal volume in children and adolescents. | Hurtado H et al. | β | 2024 | β |
| Psychosomatic Disorder: The Current Implications and Challenges. | Chauhan A et al. | β | 2024 | β |
| Risk of major mental disorders in the offspring of parents with migraine. | Li DJ et al. | β | 2024 | β |
| Self-administered generational surveys combine with genetic analysis to reveal foundations of depression in Japanese adults. | Takano R et al. | β | 2024 | β |
| [The association of polymorphisms of the serotonin transporter gene SLC6A4 with depression]. | Gafarov VV et al. | β | 2024 | β |
| The neuropsychopharmacology of acetyl-L-carnitine (LAC): basic, translational and therapeutic implications. | Bigio B et al. | β | 2024 | β |
| Transcriptomic decoding of regional cortical vulnerability to major depressive disorder. | Zhu J et al. | β | 2024 | β |
| Valence in the eyes: An emotion decoding profile of adults with major depressive disorder and a history of childhood maltreatment. | Nilsson KK et al. | β | 2024 | β |
| Association of depression phenotypes and antidepressant treatment with mortality due to cancer and other causes: a community-based cohort study. | Vilalta-Lacarra A et al. | β | 2023 | β |
| Association of reduced serum EGF and leptin levels with the pathophysiology of major depressive disorder: A case-control study. | Sohan M et al. | β | 2023 | β |
| A whole transcriptome profiling analysis for antidepressant mechanism of Xiaoyaosan mediated synapse loss via BDNF/trkB/PI3K signal axis in CUMS rats. | Meng P et al. | β | 2023 | β |
| Basal Forebrain Cholinergic Innervation Induces Depression-Like Behaviors Through Ventral Subiculum Hyperactivation. | Yu N et al. | β | 2023 | β |
| Characterization of 2 Novel Phosphodiesterase 2 Inhibitors Hcyb1 and PF-05180999 on Depression- and Anxiety-Like Behavior. | Yan Y et al. | β | 2023 | β |
| Comparative efficacy and safety of 4 atypical antipsychotics augmentation treatment for major depressive disorder in adults: A systematic review and network meta-analysis. | Wang J et al. | β | 2023 | β |
| Current and future directions of drug delivery for the treatment of mental illnesses. | Brewster PR et al. | β | 2023 | β |
| Epigenetic regulation in major depression and other stress-related disorders: molecular mechanisms, clinical relevance and therapeutic potential. | Yuan M et al. | β | 2023 | β |
| Exploratory factor analysis of shared and specific genetic associations in depression and anxiety. | Li C et al. | β | 2023 | β |
| Exploring the role of ketone bodies in the diagnosis and treatment of psychiatric disorders. | Omori NE et al. | β | 2023 | β |
| Functional connectomics in depression: insights into therapies. | Chai Y et al. | β | 2023 | β |
| Gender differences in the association of polygenic risk and divergent depression trajectories from mid to late life: a national longitudinal study. | Chen P et al. | β | 2023 | β |
| Genetic propensity, socioeconomic status, and trajectories of depression over a course of 14 years in older adults. | Kosciuszko M et al. | β | 2023 | β |
| Higher serum interleukin-12 levels are associated with the pathophysiology of major depressive disorder: A case-control study results. | Nahar Z et al. | β | 2023 | β |
| Identification and discovery of imaging genetic patterns using fusion self-expressive network in major depressive disorder. | Pang M et al. | β | 2023 | β |
| Identification of novel targets and pathways to distinguish suicide dependent or independent on depression diagnosis. | Peng S et al. | β | 2023 | β |
| Identification of shared disease marker genes and underlying mechanisms between major depression and rheumatoid arthritis. | Dmitrzak-WΔglarz M et al. | β | 2023 | β |
| Incorporating multi-stage diagnosis status to mine associations between genetic risk variants and the multi-modality phenotype network in major depressive disorder. | Zhang L et al. | β | 2023 | β |
| Integrating genetics and transcriptomics to study major depressive disorder: a conceptual framework, bioinformatic approaches, and recent findings. | Hicks EM et al. | β | 2023 | β |
| Major depressive disorders in young immigrants: A cohort study from primary healthcare settings in Sweden. | Osooli M et al. | β | 2023 | β |
| Mapping Neurophysiological Subtypes of Major Depressive Disorder Using Normative Models of the Functional Connectome. | Sun X et al. | β | 2023 | β |
| Phenotype integration improves power and preserves specificity in biobank-based genetic studies of major depressive disorder. | Dahl A et al. | β | 2023 | β |
| Plant and animal protein intake and its association with depression, anxiety, and stress among Iranian women. | Sheikhi A et al. | β | 2023 | β |
| Potential role of FKBP5 single-nucleotide polymorphisms in functional seizures. | Asadi-Pooya AA et al. | β | 2023 | β |
| Potential Roles of m6A and FTO in Synaptic Connectivity and Major Depressive Disorder. | Mitsuhashi H et al. | β | 2023 | β |
| Rasd2 Mediates Acute Fasting-Induced Antidepressant-Like Effects via Dopamine D2 Receptor Activation in Ovariectomized Mice. | Cheng Z et al. | β | 2023 | β |
| Repetitive Transcranial Magnetic Stimulation Reduces Depressive-like Behaviors, Modifies Dendritic Plasticity, and Generates Global Epigenetic Changes in the Frontal Cortex and Hippocampus in a Rodent Model of Chronic Stress. | Meneses-San Juan D et al. | β | 2023 | β |
| Sex differences in changes of depressive symptoms among older adults before and during the COVID-19 pandemic: evidence from two longitudinal cohorts. | Zheng F et al. | β | 2023 | β |
| Sex Differences in Depression and Anxiety. | Pavlidi P et al. | β | 2023 | β |
| The Association of HHV-6 and the <i>TNF-Ξ±</i> (-308G/A) Promotor with Major Depressive Disorder Patients and Healthy Controls in Thailand. | Sumala S et al. | β | 2023 | β |
| The genetic basis of major depressive disorder. | Flint J | β | 2023 | β |
| Transcriptional substrates of brain structural and functional impairments in drug-naive first-episode patients with major depressive disorder. | Fang Q et al. | β | 2023 | β |
| ADHD co-morbidities: A review of implication of gene Γ environment effects with dopamine-related genes. | Kanarik M et al. | β | 2022 | β |
| Altered hemispheric asymmetries as an endophenotype in psychological and developmental disorders: A theory on the influence of stress on brain lateralization. | Berretz G et al. | β | 2022 | β |
| A multi-environments-gene interaction study of anxiety, depression and self-harm in the UK Biobank cohort. | Li C et al. | β | 2022 | β |
| A Systematic Review of Candidate Genes for Major Depression. | Norkeviciene A et al. | β | 2022 | β |
| Cannabidiol prevents depressive-like behaviors through the modulation of neural stem cell differentiation. | Hou M et al. | β | 2022 | β |
| Convergence of Clinically Relevant Manipulations on Dopamine-Regulated Prefrontal Activity Underlying Stress Coping Responses. | Wilke SA et al. | β | 2022 | β |
| Depression and Psychosis Risk Shared Vulnerability for Motor Signs Across Development, Symptom Dimensions, and Familial Risk. | Damme KSF et al. | β | 2022 | β |
| DNA Methylation as a Therapeutic and Diagnostic Target in Major Depressive Disorder. | Lax E | β | 2022 | β |
| Effects of Allopurinol as a xanthine oxidase inhibitor on depressive-like behavior of rats and changes in serum BDNF level. | Jahromy MH et al. | β | 2022 | β |
| Evaluation of Prefrontal Ξ³-Aminobutyric Acid and Glutamate Levels in Individuals With Major Depressive Disorder Using Proton Magnetic Resonance Spectroscopy. | Ritter C et al. | β | 2022 | β |
| Gene-gene interaction and new onset of major depressive disorder: Findings from a Chinese freshmen nested case-control study. | Yue S et al. | β | 2022 | β |
| Genetic heterogeneity and subtypes of major depression. | Nguyen TD et al. | β | 2022 | β |
| Genetic variables of the glutamatergic system associated with treatment-resistant depression: A review of the literature. | Saez E et al. | β | 2022 | β |
| Gut Microbiota Metabolites in Major Depressive Disorder-Deep Insights into Their Pathophysiological Role and Potential Translational Applications. | Ortega MA et al. | β | 2022 | β |
| Identification and Characterization of Elevated Expression of Transferrin and Its Receptor TfR1 in Mouse Models of Depression. | Chang X et al. | β | 2022 | β |
| Investigating data-driven biological subtypes of psychiatric disorders using specification-curve analysis. | Beijers L et al. | β | 2022 | β |
| <i>OGDHL</i> Variant rs2293239: A Potential Genetic Driver of Chinese Familial Depressive Disorder. | Pan Z et al. | β | 2022 | β |
| Is subthreshold depression in adolescence clinically relevant? | Noyes BK et al. | β | 2022 | β |
| Major Depression and Its Recurrences: Life Course Matters. | Monroe SM et al. | β | 2022 | β |
| Motor abnormalities, depression risk, and clinical course in adolescence. | Damme KSF et al. | β | 2022 | β |
| Prenatal stress and offspring depression in adulthood: The mediating role of childhood trauma. | Liu Y et al. | β | 2022 | β |
| Psychosomatic Aspects of The Development of Comorbid Pathology: A Review. | Tatayeva R et al. | β | 2022 | β |
| Sex Difference in Global Burden of Major Depressive Disorder: Findings From the Global Burden of Disease Study 2019. | Li S et al. | β | 2022 | β |
| Sex Differences in Major Depressive Disorder (MDD) and Preclinical Animal Models for the Study of Depression. | Williams ES et al. | β | 2022 | β |
| Synapse differentiation-induced gene 1 regulates stress-induced depression through interaction with the AMPA receptor GluA2 subunit of nucleus accumbens in male mice. | Jiang L et al. | β | 2022 | β |
| The Cannabis-Induced Epigenetic Regulation of Genes Associated with Major Depressive Disorder. | Mohammad GS et al. | β | 2022 | β |
| The molecular pathophysiology of depression and the new therapeutics. | Tian H et al. | β | 2022 | β |
| The Problem of Malnutrition Associated with Major Depressive Disorder from a Sex-Gender Perspective. | GarcΓa-Montero C et al. | β | 2022 | β |
| 11Ξ²-Hydroxylase (CYP11B1) gene variants and new-onset depression in later life. | Ancelin ML et al. | β | 2021 | β |
| Analysis of Major Depression Risk Genes Reveals Evolutionary Conservation, Shared Phenotypes, and Extensive Genetic Interactions. | Sall S et al. | β | 2021 | β |
| Brain-specific Wt1 deletion leads to depressive-like behaviors in mice via the recruitment of Tet2 to modulate Epo expression. | Ji F et al. | β | 2021 | β |
| Clinical depression: the fault not in our stars? | Parker G | β | 2021 | β |
| Cognitive mechanisms underlying depressive disorders in ADHD: A systematic review. | Mayer JS et al. | β | 2021 | β |
| Deficit syndrome in Chinese patients with first-episode drug naΓ―ve schizophrenia: Prevalence, demographic and clinical characteristics. | Liu J et al. | β | 2021 | β |
| Depression and obesity among females, are sex specificities considered? | Baldini I et al. | β | 2021 | β |
| Development of Neuroimaging-Based Biomarkers in Major Depression. | Han KM et al. | β | 2021 | β |
| Dissecting diagnostic heterogeneity in depression by integrating neuroimaging and genetics. | Buch AM et al. | β | 2021 | β |
| Emerging Role of m<sup>6</sup> A Methylome in Brain Development: Implications for Neurological Disorders and Potential Treatment. | Sokpor G et al. | β | 2021 | β |
| Examining reciprocal associations between parent depressive symptoms and child internalizing symptoms on subsequent psychiatric disorders: An adoption study. | Cioffi CC et al. | β | 2021 | β |
| Exploring the Impact of Cerebrovascular Disease and Major Depression on Non-diseased Human Tissue Transcriptomes. | Poon CL et al. | β | 2021 | β |
| Exploring the Role of Nutraceuticals in Major Depressive Disorder (MDD): Rationale, State of the Art and Future Prospects. | Alvarez-Mon MA et al. | β | 2021 | β |
| Functional Contribution of the Medial Prefrontal Circuitry in Major Depressive Disorder and Stress-Induced Depressive-Like Behaviors. | Bittar TP et al. | β | 2021 | β |
| Gender, marital and educational inequalities in mid- to late-life depressive symptoms: cross-cohort variation and moderation by urbanicity degree. | Ruiz MA et al. | β | 2021 | β |
| Genetic Architecture of Depression: Where Do We Stand Now? | Unal-Aydin P et al. | β | 2021 | β |
| Genome-wide mapping of brain phenotypes in extended pedigrees with strong genetic loading for bipolar disorder. | Fears SC et al. | β | 2021 | β |
| Influence of functional gene polymorphisms on human behaviour: the case of <i>CCR5</i>. | Albert PR | β | 2021 | β |
| Internalizing and neurodevelopmental problems in young people: Educational outcomes in a large population-based cohort of twins. | Doering S et al. | β | 2021 | β |
| Investigating regions of shared genetic variation in attention deficit/hyperactivity disorder and major depressive disorder: a GWAS meta-analysis. | Powell V et al. | β | 2021 | β |
| Mendelian randomization integrating GWAS and eQTL data revealed genes pleiotropically associated with major depressive disorder. | Yang H et al. | β | 2021 | β |
| Myrsinoic acid B from Myrsine coriacea reverses depressive-like behavior and brain oxidative stress in streptozotocin-diabetic rats. | Zimath PL et al. | β | 2021 | β |
| Neurocognitive and functional heterogeneity in depressed youth. | Baller EB et al. | β | 2021 | β |
| Of adenosine and the blues: The adenosinergic system in the pathophysiology and treatment of major depressive disorder. | Gomes JI et al. | β | 2021 | β |
| Oligonucleotides as therapeutic tools for brain disorders: Focus on major depressive disorder and Parkinson's disease. | Bortolozzi A et al. | β | 2021 | β |
| Phosphodiesterase 8A to discriminate in blood samples depressed patients and suicide attempters from healthy controls based on A-to-I RNA editing modifications. | Salvetat N et al. | β | 2021 | β |
| Polygenic risk for depression, anxiety and neuroticism are associated with the severity and rate of change in depressive symptoms across adolescence. | Kwong ASF et al. | β | 2021 | β |
| Prefrontal cortex miR-874-3p prevents lipopolysaccharide-induced depression-like behavior through inhibition of indoleamine 2,3-dioxygenase 1 expression in mice. | Suento WJ et al. | β | 2021 | β |
| Private Insurance and Mental Health among Older Adults with Multiple Chronic Conditions: A Longitudinal Analysis by Race and Ethnicity. | Jun H et al. | β | 2021 | β |
| Sex differences in mental health among older adults: investigating time trends and possible risk groups with regard to age, educational level and ethnicity. | Sialino LD et al. | β | 2021 | β |
| Smartphones and the Neuroscience of Mental Health. | Gillan CM et al. | β | 2021 | β |
| Sperm microRNAs confer depression susceptibility to offspring. | Wang Y et al. | β | 2021 | β |
| Steroid 21-hydroxylase gene variants and late-life depression. | Ancelin ML et al. | β | 2021 | β |
| The associations of CNR1 SNPs and haplotypes with vulnerability and treatment response phenotypes in Han Chinese with major depressive disorder: A case-control association study. | Yang C et al. | β | 2021 | β |
| The Contagion of Psychopathology across Different Psychiatric Disorders: A Comparative Theoretical Analysis. | Horesh D et al. | β | 2021 | β |
| The genetic basis of major depression. | Kendall KM et al. | β | 2021 | β |
| Transcriptional-regulatory convergence across functional MDD risk variants identified by massively parallel reporter assays. | Mulvey B et al. | β | 2021 | β |
| Whole genome sequencing of nearly isogenic WMI and WLI inbred rats identifies genes potentially involved in depression and stress reactivity. | de Jong TV et al. | β | 2021 | β |
| 5HTTLPR Genetic Variant and Major Depressive Disorder: A Review. | Fratelli C et al. | β | 2020 | β |
| Analyzing the genes and pathways related to major depressive disorder via a systems biology approach. | Fan T et al. | β | 2020 | β |
| A phenome-wide association and Mendelian Randomisation study of polygenic risk for depression in UK Biobank. | Shen X et al. | β | 2020 | β |
| Associations between disordered gut microbiota and changes of neurotransmitters and short-chain fatty acids in depressed mice. | Wu M et al. | β | 2020 | β |
| A study combining whole-exome sequencing and structural neuroimaging analysis for major depressive disorder. | Han KM et al. | β | 2020 | β |
| Bound Together: How Psychoanalysis Diminishes Inter-generational DNA Trauma. | Colangeli R | β | 2020 | β |
| Childhood Adoption and Mental Health in Adulthood: The Role of Gene-Environment Correlations and Interactions in the UK Biobank. | Lehto K et al. | β | 2020 | β |
| Comparative efficacy and acceptability of traditional Chinese medicine for adult major depression: A protocol for network meta-analysis. | Shao Y et al. | β | 2020 | β |
| Developmental trajectories to reduced activation of positive valence systems: A review of biological and environmental contributions. | Kujawa A et al. | β | 2020 | β |
| Distinct subtypes of polycystic ovary syndrome with novel genetic associations: An unsupervised, phenotypic clustering analysis. | Dapas M et al. | β | 2020 | β |
| Effect of the <i>SIRT1</i> gene on regional cortical grey matter density in the Han Chinese population. | Rao S et al. | β | 2020 | β |
| ENIGMA MDD: seven years of global neuroimaging studies of major depression through worldwide data sharing. | Schmaal L et al. | β | 2020 | β |
| Gene-Based Association Analysis Suggests Association of <i>HTR2A</i> With Antidepressant Treatment Response in Depressed Patients. | Kao CF et al. | β | 2020 | β |
| Genetic Influences on Disease Subtypes. | Dahl A et al. | β | 2020 | β |
| Genetic variants associated with psychotic symptoms across psychiatric disorders. | CalabrΓ² M et al. | β | 2020 | β |
| Immune dysregulation in depression: Evidence from genome-wide association. | Tubbs JD et al. | β | 2020 | β |
| Increased relapse to cocaine-seeking in a genetic model for depression. | Zilkha N et al. | β | 2020 | β |
| Machine learning for effectively avoiding overfitting is a crucial strategy for the genetic prediction of polygenic psychiatric phenotypes. | Takahashi Y et al. | β | 2020 | β |
| Minimal phenotyping yields genome-wide association signals of low specificity for major depression. | Cai N et al. | β | 2020 | β |
| Nature and Nurture: Effects of Affective Temperaments on Depressive Symptoms Are Markedly Modified by Stress Exposure. | Gonda X et al. | β | 2020 | β |
| Predicting SSRI-Resistance: Clinical Features and tagSNPs Prediction Models Based on Support Vector Machine. | Zhang H et al. | β | 2020 | β |
| Reviewing the genetics of heterogeneity in depression: operationalizations, manifestations and etiologies. | Cai N et al. | β | 2020 | β |
| Roles of 5,10-Methylenetetrahydrofolate Reductase C677T Polymorphisms in First-Episode, Drug-Naive Adult Patients With Depression. | Li Z et al. | β | 2020 | β |
| Stratifying major depressive disorder by polygenic risk for schizophrenia in relation to structural brain measures. | Harris MA et al. | β | 2020 | β |
| Systemic neuro-dysregulation in depression: Evidence from genome-wide association. | Tubbs JD et al. | β | 2020 | β |
| The clinical characterization of the adult patient with depression aimed at personalization of management. | Maj M et al. | β | 2020 | β |
| The Emerging Role of SGK1 (Serum- and Glucocorticoid-Regulated Kinase 1) in Major Depressive Disorder: Hypothesis and Mechanisms. | Dattilo V et al. | β | 2020 | β |
| Toward a New Model of Understanding, Preventing, and Treating Adolescent Depression Focusing on Exhaustion and Stress. | van der Gronde T et al. | β | 2020 | β |
| Adolescent and adult differences in major depression symptom profiles. | Rice F et al. | β | 2019 | β |
| Association between area deprivation and major depressive disorder in British men and women: a cohort study. | Remes O et al. | β | 2019 | β |
| Association between negative cognitive bias and depression: A symptom-level approach. | Beevers CG et al. | β | 2019 | β |
| Association of a Schizophrenia-Risk Nonsynonymous Variant With Putamen Volume in Adolescents: A Voxelwise and Genome-Wide Association Study. | Luo Q et al. | β | 2019 | β |
| Characterizing Developmental Trajectories and the Role of Neuropsychiatric Genetic Risk Variants in Early-Onset Depression. | Rice F et al. | β | 2019 | β |
| Circadian regulation of depression: A role for serotonin. | Daut RA et al. | β | 2019 | β |
| Constitutive Serotonin Transporter Reduction Resembles Maternal Separation with Regard to Stress-Related Gene Expression. | Comasco E et al. | β | 2019 | β |
| Depression in neurodegenerative diseases: Common mechanisms and current treatment options. | Galts CPC et al. | β | 2019 | β |
| Depressive disorders: Treatment failures and poor prognosis over the last 50Β years. | Blackburn TP | β | 2019 | β |
| Effects of Different Stressors Are Modulated by Different Neurobiological Systems: The Role of GABA-A Versus CB1 Receptor Gene Variants in Anxiety and Depression. | Gonda X et al. | β | 2019 | β |
| Epigenome-wide association study of depression symptomatology in elderly monozygotic twins. | Starnawska A et al. | β | 2019 | β |
| Genetic variants in major depressive disorder: From pathophysiology to therapy. | Gonda X et al. | β | 2019 | β |
| Genome-wide association study of multisite chronic pain in UK Biobank. | Johnston KJA et al. | β | 2019 | β |
| GWAS and systems biology analysis of depressive symptoms among smokers from the COPDGene cohort. | Heinzman JT et al. | β | 2019 | β |
| Icariin and icaritin ameliorated hippocampus neuroinflammation via mediating HMGB1 expression in social defeat model in mice. | Liu L et al. | β | 2019 | β |
| Identification of novel common variants associated with chronic pain using conditional false discovery rate analysis with major depressive disorder and assessment of pleiotropic effects of LRFN5. | Johnston KJA et al. | β | 2019 | β |
| Male infants and birth complications are associated with increased incidence of postnatal depression. | Myers S et al. | β | 2019 | β |
| Mitochondria: A Connecting Link in the Major Depressive Disorder Jigsaw. | Sharma S et al. | β | 2019 | β |
| Neonatal Immune Activation May Provoke Long-term Depressive Attributes. | Schelder-Marzzani SH et al. | β | 2019 | β |
| Neuroimaging Advance in Depressive Disorder. | Peng D et al. | β | 2019 | β |
| Neuroimmune nexus of depression and dementia: Shared mechanisms and therapeutic targets. | Herman FJ et al. | β | 2019 | β |
| New considerations for hiPSC-based models of neuropsychiatric disorders. | Hoffman GE et al. | β | 2019 | β |
| Parental consanguinity in patients with psychogenic nonepileptic seizures. | Asadi-Pooya AA et al. | β | 2019 | β |
| Poor peer relations in adolescence, social support in early adulthood, and depressive symptoms in later adulthood-evaluating mediation and interaction using four-way decomposition analysis. | Bean CG et al. | β | 2019 | β |
| Reverse GWAS: Using genetics to identify and model phenotypic subtypes. | Dahl A et al. | β | 2019 | β |
| Role of inflammation in depression relapse. | Liu CH et al. | β | 2019 | β |
| Selecting an Appropriate Animal Model of Depression. | Hao Y et al. | β | 2019 | β |
| Sex differences in depression: Insights from clinical and preclinical studies. | Eid RS et al. | β | 2019 | β |
| Sex Differences in Intergenerational Transfer Risk of Major Depressive Disorder. | Fang G et al. | β | 2019 | β |
| Targeting Gap Junctions: New Insights into the Treatment of Major Depressive Disorder. | Sarrouilhe D et al. | β | 2019 | β |
| The association of psychosocial risk factors for mental health with a brain marker altered by inflammation: A translocator protein (TSPO) PET imaging study. | Dahoun T et al. | β | 2019 | β |
| The future of rodent models in depression research. | Gururajan A et al. | β | 2019 | β |
| Towards a Phenomenology of Self-Patterns in Psychopathological Diagnosis and Therapy. | Daly A et al. | β | 2019 | β |
| Twin-based heritability of actimetry traits. | Gehrman PR et al. | β | 2019 | β |
| Whole Exome Sequencing Identifies a Novel Predisposing Gene, MAPKAP1, for Familial Mixed Mood Disorder. | Yang C et al. | β | 2019 | β |
| A comprehensive regional neurochemical theory in depression: a protocol for the systematic review and meta-analysis of 1H-MRS studies in major depressive disorder. | Drago T et al. | β | 2018 | β |
| Agmatine potentiates neuroprotective effects of subthreshold concentrations of ketamine via mTOR/S6 kinase signaling pathway. | Tavares MK et al. | β | 2018 | β |
| Association of Genetic Variation at <i>AQP4</i> Locus with Vascular Depression. | Westermair AL et al. | β | 2018 | β |
| Associations of Smoking, Physical Inactivity, Heavy Drinking, and Obesity with Quality-Adjusted Life Expectancy among US Adults with Depression. | Jia H et al. | β | 2018 | β |
| [A study on the association of genes for pro-inflammatory cytokines and depression]. | Lezheiko TV et al. | β | 2018 | β |
| Can flow experiences be protective of work-related depressive symptoms and burnout? A genetically informative approach. | Mosing MA et al. | β | 2018 | β |
| Childhood adversity as a transdiagnostic risk factor for affective disorders in adulthood: A systematic review focusing on biopsychosocial moderating and mediating variables. | Hoppen TH et al. | β | 2018 | β |
| Collaborative meta-analysis finds no evidence of a strong interaction between stress and 5-HTTLPR genotype contributing to the development of depression. | Culverhouse RC et al. | β | 2018 | β |
| Common variants on 6q16.2, 12q24.31 and 16p13.3 are associated with major depressive disorder. | Li X et al. | β | 2018 | β |
| Correlations between caregiver psychiatric symptoms and offspring psychopathology in a low-resource setting. | Matsuzaka CT et al. | β | 2018 | β |
| Cross-species evidence from human and rat brain transcriptome for growth factor signaling pathway dysregulation in major depression. | Carboni L et al. | β | 2018 | β |
| Depression. | Malhi GS et al. | β | 2018 | β |
| Dynamical Relations in the Self-Pattern. | Gallagher S et al. | β | 2018 | β |
| Embracing polygenicity: a review of methods and tools for psychiatric genetics research. | Maier RM et al. | β | 2018 | β |
| Fibroblast growth factor 2 regulates activity and gene expression of human post-mitotic excitatory neurons. | Gupta S et al. | β | 2018 | β |
| Genetics Factors in Major Depression Disease. | Shadrina M et al. | β | 2018 | β |
| Genome-wide gene-environment interaction in depression: A systematic evaluation of candidate genes: The childhood trauma working-group of PGC-MDD. | Van der Auwera S et al. | β | 2018 | β |
| Genome-wide meta-analyses of stratified depression in Generation Scotland and UK Biobank. | Hall LS et al. | β | 2018 | β |
| Glucocorticoid Receptor Genetic Variants and Response to Fluoxetine in Major Depressive Disorder. | Nouraei H et al. | β | 2018 | β |
| Identification of novel common variants associated with chronic pain using conditional false discovery rate analysis with major depressive disorder and assessment of pleiotropic effects of <i>LRFN5</i> | Johnston KJ et al. | β | 2018 | β |
| Interactions Among Polymorphisms of Susceptibility Loci for Alzheimer's Disease or Depressive Disorder. | KitzlerovΓ‘ E et al. | β | 2018 | β |
| Intergenerational Continuity in Depression: The Importance of Time-Varying Effects, Maternal Co-morbid Health Risk Behaviors and Child's Gender. | Augustyn MB et al. | β | 2018 | β |
| Issues on the diagnosis and etiopathogenesis of mood disorders: reconsidering DSM-5. | Ogasawara K et al. | β | 2018 | β |
| Long Noncoding RNA-Associated Transcriptomic Changes in Resiliency or Susceptibility to Depression and Response to Antidepressant Treatment. | Roy B et al. | β | 2018 | β |
| Low-frequency and rare variants may contribute to elucidate the genetics of major depressive disorder. | Yu C et al. | β | 2018 | β |
| Mapping risk factors for depression across the lifespan: An umbrella review of evidence from meta-analyses and Mendelian randomization studies. | KΓΆhler CA et al. | β | 2018 | β |
| Molecular Genetic Analysis Subdivided by Adversity Exposure Suggests Etiologic Heterogeneity in Major Depression. | Peterson RE et al. | β | 2018 | β |
| Neuroimaging genomic studies in major depressive disorder: A systematic review. | Zhang HF et al. | β | 2018 | β |
| Relevance of Rodent Models of Depression in Clinical Practice: Can We Overcome the Obstacles in Translational Neuropsychiatry? | SΓΆderlund J et al. | β | 2018 | β |
| Response to therapeutic sleep deprivation: a naturalistic study of clinical and genetic factors and post-treatment depressive symptom trajectory. | Trautmann N et al. | β | 2018 | β |
| Review: Longitudinal trajectories of child and adolescent depressive symptoms and their predictors - a systematic review and meta-analysis. | Shore L et al. | β | 2018 | β |
| Serotonin in psychiatry: in vitro disease modeling using patient-derived neurons. | Vadodaria KC et al. | β | 2018 | β |
| The Curious Neglect of High Functioning After Psychopathology: The Case of Depression. | Rottenberg J et al. | β | 2018 | β |
| The effect of weight on mental health: New evidence using genetic IVs. | Willage B | β | 2018 | β |
| Understanding the pathophysiology of depression: From monoamines to the neurogenesis hypothesis model - are we there yet? | Jesulola E et al. | β | 2018 | β |
| Vesicular glutamate transporter 1 (VGLUT1)-mediated glutamate release and membrane GluA1 activation is involved in the rapid antidepressant-like effects of scopolamine in mice. | Yu H et al. | β | 2018 | β |
| 11,670 whole-genome sequences representative of the Han Chinese population from the CONVERGE project. | Cai N et al. | β | 2017 | β |
| A comprehensive regional analysis of genome-wide expression profiles for major depressive disorder. | Forero DA et al. | β | 2017 | β |
| Adolescent Major Depressive Disorder: Neuroimaging Evidence of Sex Difference during an Affective Go/No-Go Task. | Chuang JY et al. | β | 2017 | β |
| A Preliminary Study of Genetic Variation in the Dopaminergic and Serotonergic Systems and Genome-wide Additive Genetic Effects on Depression Severity and Treatment Response. | Palmer RH et al. | β | 2017 | β |
| Assessing the presence of shared genetic architecture between Alzheimer's disease and major depressive disorder using genome-wide association data. | Gibson J et al. | β | 2017 | β |
| Association of body mass index-related single nucleotide polymorphisms with psychiatric disease and memory performance in a Japanese population. | Ninomiya-Baba M et al. | β | 2017 | β |
| Can clinical subtypes contribute to genetic studies on major depression? | Caldieraro MA et al. | β | 2017 | β |
| Depressive symptom trajectories in late adolescence and early adulthood: A systematic review. | Schubert KO et al. | β | 2017 | β |
| Expert and self-assessment of lifetime symptoms and diagnosis of major depressive disorder in large-scale genetic studies in the general population: comparison of a clinical interview and a self-administered checklist. | Martin J et al. | β | 2017 | β |
| Gene-based interaction analysis shows GABAergic genes interacting with parenting in adolescent depressive symptoms. | Van Assche E et al. | β | 2017 | β |
| Gene expression in blood of children and adolescents: Mediation between childhood maltreatment and major depressive disorder. | Spindola LM et al. | β | 2017 | β |
| Genetic Approaches to Understanding Psychiatric Disease. | Michaelson JJ | β | 2017 | β |
| Genetic effects influencing risk for major depressive disorder in China and Europe. | Bigdeli TB et al. | β | 2017 | β |
| Genetic Studies on the Tripartite Glutamate Synapse in the Pathophysiology and Therapeutics of Mood Disorders. | de Sousa RT et al. | β | 2017 | β |
| Genome-wide Regional Heritability Mapping Identifies a Locus Within the TOX2 Gene Associated With Major Depressive Disorder. | Zeng Y et al. | β | 2017 | β |
| High-Coverage Whole-Exome Sequencing Identifies Candidate Genes for Suicide in Victims with Major Depressive Disorder. | TombΓ‘cz D et al. | β | 2017 | β |
| Hostile parenting, parental psychopathology, and depressive symptoms in the offspring: a 32-year follow-up in the Young Finns study. | Gluschkoff K et al. | β | 2017 | β |
| Identifying genes for neurobehavioural traits in rodents: progress and pitfalls. | Baud A et al. | β | 2017 | β |
| Imaging Genetics and Genomics in Psychiatry: A Critical Review of Progress and Potential. | Bogdan R et al. | β | 2017 | β |
| Like mother like daughter: putamen activation as a mechanism underlying intergenerational risk for depression. | Colich NL et al. | β | 2017 | β |
| Major depressive disorder, suicidal thoughts and behaviours, and cannabis involvement in discordant twins: a retrospective cohort study. | Agrawal A et al. | β | 2017 | β |
| Mercy Pregnancy and Emotional Well-being Study (MPEWS): Understanding maternal mental health, fetal programming and child development. Study design and cohort profile. | Galbally M et al. | β | 2017 | β |
| Nonsynonymous Variation in NKPD1 Increases Depressive Symptoms in European Populations. | Amin N et al. | β | 2017 | β |
| Pharmacogenomics in the treatment of mood disorders: Strategies and Opportunities for personalized psychiatry. | Amare AT et al. | β | 2017 | β |
| Polymorphism of ERK/PTPRR Genes in Major Depressive Disorder at Resting-State Brain Function. | Wang Y et al. | β | 2017 | β |
| Prepubertal Ovariectomy Exaggerates Adult Affective Behaviors and Alters the Hippocampal Transcriptome in a Genetic Rat Model of Depression. | Raghavan NS et al. | β | 2017 | β |
| Sex-specific transcriptional signatures in human depression. | LabontΓ© B et al. | β | 2017 | β |
| Stability and change in etiological factors for alcohol use disorder and major depression. | Torvik FA et al. | β | 2017 | β |
| Systematic review and meta-analysis of genetic studies of late-life depression. | Tsang RS et al. | β | 2017 | β |
| Testing the psychological pain hypothesis for postnatal depression: Reproductive success versus evidence of design. | Hagen EH et al. | β | 2017 | β |
| Text mining and expert curation to develop a database on psychiatric diseases and their genes. | GutiΓ©rrez-SacristΓ‘n A et al. | β | 2017 | β |
| The Anorexia Nervosa Genetics Initiative: Study description and sample characteristics of the Australian and New Zealand arm. | Kirk KM et al. | β | 2017 | β |
| The Genetic Architecture of Major Depressive Disorder in Han Chinese Women. | Peterson RE et al. | β | 2017 | β |
| The interaction of miR-34b/c polymorphisms and negative life events increases susceptibility to major depressive disorder in Han Chinese population. | Xu C et al. | β | 2017 | β |
| The use of behavioural genetics in the criminal justice system: A disability & human rights perspective. | O'Mahony C et al. | β | 2017 | β |
| Using Clinical Characteristics to Identify Which Patients With Major Depressive Disorder Have a Higher Genetic Load for Three Psychiatric Disorders. | Verduijn J et al. | β | 2017 | β |
| Vascular Dementia. | O'Brien JT et al. | β | 2017 | β |
| Whole-genome single nucleotide variant distribution on genomic regions and its relationship to major depression. | Yu C et al. | β | 2017 | β |
| Why is depression more common among women than among men? | Kuehner C | β | 2017 | β |
| Altered Disrupted-in-Schizophrenia-1 Function Affects the Development of Cortical Parvalbumin Interneurons by an Indirect Mechanism. | Borkowska M et al. | β | 2016 | β |
| A method to decipher pleiotropy by detecting underlying heterogeneity driven by hidden subgroups applied to autoimmune and neuropsychiatric diseases. | Han B et al. | β | 2016 | β |
| Biological underpinnings of psychogenic nonepileptic seizures: directions for future research. | Asadi-Pooya AA | β | 2016 | β |
| Blood-based gene expression signatures of medication-free outpatients with major depressive disorder: integrative genome-wide and candidate gene analyses. | Hori H et al. | β | 2016 | β |
| Common variants in FKBP5 gene and major depressive disorder (MDD) susceptibility: a comprehensive meta-analysis. | Rao S et al. | β | 2016 | β |
| Depression-like episodes in mice harboring mtDNA deletions in paraventricular thalamus. | Kasahara T et al. | β | 2016 | β |
| Differential Vulnerability to Early-Life Parental Death: The Moderating Effects of Family Suicide History on Risks for Major Depression and Substance Abuse in Later Life. | Hollingshaus MS et al. | β | 2016 | β |
| Distinct effects of folate pathway genes MTHFR and MTHFD1L on ruminative response style: a potential risk mechanism for depression. | Eszlari N et al. | β | 2016 | β |
| Does refining the phenotype improve replication rates? A review and replication of candidate gene studies on Major Depressive Disorder and Chronic Major Depressive Disorder. | Luo X et al. | β | 2016 | β |
| Effects of anti-depressant treatments on FADD and p-FADD protein in rat brain cortex: enhanced anti-apoptotic p-FADD/FADD ratio after chronic desipramine and fluoxetine administration. | GarcΓa-Fuster MJ et al. | β | 2016 | β |
| Genetic and environmental components of female depression as a function of the severity of the disorder. | Rusby JS et al. | β | 2016 | β |
| Genetic Moderation of Stress Effects on Corticolimbic Circuitry. | Bogdan R et al. | β | 2016 | β |
| GENOME-WIDE ASSOCIATION STUDY (GWAS) AND GENOME-WIDE BY ENVIRONMENT INTERACTION STUDY (GWEIS) OF DEPRESSIVE SYMPTOMS IN AFRICAN AMERICAN AND HISPANIC/LATINA WOMEN. | Dunn EC et al. | β | 2016 | β |
| Genome-wide linkage on chromosome 10q26 for a dimensional scale of major depression. | Knowles EE et al. | β | 2016 | β |
| High-throughput sequencing of the synaptome in major depressive disorder. | Pirooznia M et al. | β | 2016 | β |
| Identification of SLC25A37 as a major depressive disorder risk gene. | Huo YX et al. | β | 2016 | β |
| Influence of ACE gene on differential response to sertraline versus fluoxetine in patients with major depression: a randomized controlled trial. | Bahramali E et al. | β | 2016 | β |
| Major depressive disorder. | Otte C et al. | β | 2016 | β |
| Nature and nurture: environmental influences on a genetic rat model of depression. | Mehta-Raghavan NS et al. | β | 2016 | β |
| Novel variants in ZNF34 and other brain-expressed transcription factors are shared among early-onset MDD relatives. | Subaran RL et al. | β | 2016 | β |
| Pathogenesis of depression: Insights from human and rodent studies. | MΓ©nard C et al. | β | 2016 | β |
| Polygenic dissection of major depression clinical heterogeneity. | Milaneschi Y et al. | β | 2016 | β |
| Polygenic interactions with environmental adversity in the aetiology of major depressive disorder. | Mullins N et al. | β | 2016 | β |
| Recurrent major depression and right hippocampal volume: A bivariate linkage and association study. | Mathias SR et al. | β | 2016 | β |
| Role of Mitochondrial Dynamics in Neuronal Development: Mechanism for Wolfram Syndrome. | Cagalinec M et al. | β | 2016 | β |
| Seeking an objective diagnosis of depression. | Bilello JA | β | 2016 | β |
| Shared Genetics and Couple-Associated Environment Are Major Contributors to the Risk of Both Clinical and Self-Declared Depression. | Zeng Y et al. | β | 2016 | β |
| [Significance of the German Act on the Reform of the Market for Medicinal Products for psychopharmacotherapy]. | GrΓΌnder G | β | 2016 | β |
| Systems Genomics Support for Immune and Inflammation Hypothesis of Depression. | Sharma A | β | 2016 | β |
| The First Pilot Genome-Wide Gene-Environment Study of Depression in the Japanese Population. | Otowa T et al. | β | 2016 | β |
| The future of psychiatric research. | Caldieraro MA | β | 2016 | β |
| The Genetics of Stress-Related Disorders: PTSD, Depression, and Anxiety Disorders. | Smoller JW | β | 2016 | β |
| The relevance of 'mixed anxiety and depression' as a diagnostic category in clinical practice. | MΓΆller HJ et al. | β | 2016 | β |
| The road to precision psychiatry: translating genetics into disease mechanisms. | Gandal MJ et al. | β | 2016 | β |
| The ROOTS study: a 10-year review of findings on adolescent depression, and recommendations for future longitudinal research. | Lewis G et al. | β | 2016 | β |
| Understanding the impact of 5-HTTLPR, antidepressants, and acute tryptophan depletion on brain activation during facial emotion processing: A review of the imaging literature. | Raab K et al. | β | 2016 | β |
| Aberrant NMDA receptor DNA methylation detected by epigenome-wide analysis of hippocampus and prefrontal cortex in major depression. | Kaut O et al. | β | 2015 | β |
| A Genetic Susceptibility Mechanism for Major Depression: Combinations of polymorphisms Defined the Risk of Major Depression and Subpopulations. | Wang Y et al. | β | 2015 | β |
| Alterations in circadian entrainment precede the onset of depression-like behavior that does not respond to fluoxetine. | Spulber S et al. | β | 2015 | β |
| A Mouse Model of Subchronic and Mild Social Defeat Stress for Understanding Stress-induced Behavioral and Physiological Deficits. | Goto T et al. | β | 2015 | β |
| An excitatory synapse hypothesis of depression. | Thompson SM et al. | β | 2015 | β |
| Baseline brain perfusion and brain structure in patients with major depression: a multimodal magnetic resonance imaging study. | Vasic N et al. | β | 2015 | β |
| Behavioral studies on anxiety and depression in a drug discovery environment: keys to a successful future. | Bouwknecht JA | β | 2015 | β |
| Biological and psychosocial predictors of postpartum depression: systematic review and call for integration. | Yim IS et al. | β | 2015 | β |
| Corticosterone mediates the synaptic and behavioral effects of chronic stress at rat hippocampal temporoammonic synapses. | Kvarta MD et al. | β | 2015 | β |
| Differential induction of FosB isoforms throughout the brain by fluoxetine and chronic stress. | Vialou V et al. | β | 2015 | β |
| Discovering schizophrenia endophenotypes in randomly ascertained pedigrees. | Glahn DC et al. | β | 2015 | β |
| DSM-5 reviewed from different angles: goal attainment, rationality, use of evidence, consequences--part 1: general aspects and paradigmatic discussion of depressive disorders. | MΓΆller HJ et al. | β | 2015 | β |
| DSM-5 reviewed from different angles: goal attainment, rationality, use of evidence, consequencesβpart 2: bipolar disorders, schizophrenia spectrum disorders, anxiety disorders, obsessive-compulsive disorders, trauma- and stressor-related disorders, personality disorders, substance-related and addictive disorders, neurocognitive disorders. | MΓΆller HJ et al. | β | 2015 | β |
| Early life trauma, depression and the glucocorticoid receptor gene--an epigenetic perspective. | Smart C et al. | β | 2015 | β |
| Effect of desipramine on gene expression in the mouse frontal cortex - microarray study. | Solich J et al. | β | 2015 | β |
| Epidemiological support for genetic variability at hypothalamic-pituitary-adrenal axis and serotonergic system as risk factors for major depression. | Ching-LΓ³pez A et al. | β | 2015 | β |
| Epidemiology and Heritability of Major Depressive Disorder, Stratified by Age of Onset, Sex, and Illness Course in Generation Scotland: Scottish Family Health Study (GS:SFHS). | Fernandez-Pujals AM et al. | β | 2015 | β |
| GABAergic control of depression-related brain states. | Luscher B et al. | β | 2015 | β |
| Genetic analyses benefit from using less heterogeneous phenotypes: an illustration with the hospital anxiety and depression scale (HADS). | Laurin CA et al. | β | 2015 | β |
| Heterogeneity and individuality: microRNAs in mental disorders. | Hommers LG et al. | β | 2015 | β |
| Identification of genes and gene pathways associated with major depressive disorder by integrative brain analysis of rat and human prefrontal cortex transcriptomes. | Malki K et al. | β | 2015 | β |
| In pursuit of neuroimaging biomarkers to guide treatment selection in major depressive disorder: a review of the literature. | Lener MS et al. | β | 2015 | β |
| Is serotonin an upper or a downer? The evolution of the serotonergic system and its role in depression and the antidepressant response. | Andrews PW et al. | β | 2015 | β |
| Is there a "metabolic-mood syndrome"? A review of the relationship between obesity and mood disorders. | Mansur RB et al. | β | 2015 | β |
| Ketamine and other potential glutamate antidepressants. | Dutta A et al. | β | 2015 | β |
| Layer 2/3 pyramidal cells in the medial prefrontal cortex moderate stress induced depressive behaviors. | Shrestha P et al. | β | 2015 | β |
| Molecular and Genetic Characterization of Depression: Overlap with other Psychiatric Disorders and Aging. | Ding Y et al. | β | 2015 | β |
| Monoamine-sensitive developmental periods impacting adult emotional and cognitive behaviors. | Suri D et al. | β | 2015 | β |
| No Association of BDNF, COMT, MAOA, SLC6A3, and SLC6A4 Genes and Depressive Symptoms in a Sample of Healthy Colombian Subjects. | GonzΓ‘lez-Giraldo Y et al. | β | 2015 | β |
| Postnatal loss of hap1 reduces hippocampal neurogenesis and causes adult depressive-like behavior in mice. | Xiang J et al. | β | 2015 | β |
| Probing the stress and depression circuits with a disease gene. | Park CS et al. | β | 2015 | β |
| Replication of the association of GLT6D1 with aggressive periodontitis in a Sudanese population. | Hashim NT et al. | β | 2015 | β |
| Risk assessment and predicting outcomes in patients with depressive symptoms: a review of potential role of peripheral blood based biomarkers. | Jani BD et al. | β | 2015 | β |
| Shared Genetic Factors of Anxiety and Depression Symptoms in a Brazilian Family-Based Cohort, the Baependi Heart Study. | Taporoski TP et al. | β | 2015 | β |
| Sparse whole-genome sequencing identifies two loci for major depressive disorder. | CONVERGE consortium | β | 2015 | β |
| The contribution of proteomic studies in humans, animal models, and after antidepressant treatments to investigate the molecular neurobiology of major depression. | Carboni L | β | 2015 | β |
| The interaction between stress and genetic factors in the etiopathogenesis of depression. | McGuffin P et al. | β | 2015 | β |
| The promise of biomarkers in diagnosing major depression in primary care: the present and future. | Redei EE et al. | β | 2015 | β |
| Two Chronic Stress Models Based on Movement Restriction in Rats Respond Selectively to Antidepressant Drugs: Aldolase C As a Potential Biomarker. | Ampuero E et al. | β | 2015 | β |
| Variability in the effect of 5-HTTLPR on depression in a large European population: the role of age, symptom profile, type and intensity of life stressors. | Juhasz G et al. | β | 2015 | β |
| Vascular dementia. | O'Brien JT et al. | β | 2015 | β |
| Whole genome/exome sequencing in mood and psychotic disorders. | Kato T | β | 2015 | β |
| A polygenic risk score associated with measures of depressive symptoms among older adults. | Levine ME et al. | β | 2014 | β |
| Commentary: Response to commentary by Rutter on Munafo et al. (2014). | MunafΓ² MR et al. | β | 2014 | β |
| Does poor health predict moving, move quality, and desire to move?: A study examining neighborhood selection in US adolescents and adults. | Dunn EC et al. | β | 2014 | β |
| Etiological heterogeneity of symptom dimensions of adolescent depression. | Chen J et al. | β | 2014 | β |
| Genetics: finding genes for schizophrenia. | Flint J et al. | β | 2014 | β |
| Genome-Wide Analyses of Working-Memory Ability: A Review. | Knowles EE et al. | β | 2014 | β |
| Integrating genetics and social science: genetic risk scores. | Belsky DW et al. | β | 2014 | β |
| Intermediate phenotypes and biomarkers of treatment outcome in major depressive disorder. | Leuchter AF et al. | β | 2014 | β |
| Modeling the dynamics of disease states in depression. | Demic S et al. | β | 2014 | β |
| The genetic interacting landscape of 63 candidate genes in Major Depressive Disorder: an explorative study. | Lekman M et al. | β | 2014 | β |
| The neuroscience of depression: implications for assessment and intervention. | Singh MK et al. | β | 2014 | β |